Tina M. Albertson

Insider Reports History

Entity
Individual
Location
C/O Lyell Immunopharma, Inc., 201 Haskins Way, South San Francisco, CA
Signature
/s/ Barbara G. McClung, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tina M. Albertson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Medical Officer Common Stock 4.05K $9.23K $2.28 Feb 24, 2023 Direct
Lyell Immunopharma, Inc. Chief Medical Officer Option (right to buy) 700K Feb 24, 2023 Direct
Caribou Biosciences, Inc. Chief Medical Officer Option to purchase Common Stock 300K Aug 19, 2024 Direct

Insider Reports Filed by Tina M. Albertson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRBU Caribou Biosciences, Inc. Aug 19, 2024 1 $0 4 Aug 20, 2024 Chief Medical Officer
CRBU Caribou Biosciences, Inc. Aug 12, 2024 0 $0 3 Aug 20, 2024 Chief Medical Officer
LYEL Lyell Immunopharma, Inc. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Medical Officer
LYEL Lyell Immunopharma, Inc. Mar 23, 2022 0 $0 3 Mar 29, 2022 Chief Medical Officer